Effects of Steroid Injection With Percutaneous Needle Aponeurotomy in Dupuytren's Contracture

PHASE3CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

August 31, 2011

Study Completion Date

June 30, 2013

Conditions
Dupuytren's Contracture
Interventions
DRUG

Triamcinolone Acetonide

"* Triamcinolone acetonide will be administered into the cord following surgery with a tuberculin syringe and a 25-gauge needle.~* Doses will range from 60-120 mg depending on extent of the disease.~* Patients will receive injections at 6 weeks and 3 months for persisting nodules or cords.~* PI will determine the dosages. Estimates will be made based on the following:~Size of nodule/cord: 1-2 cm2, dosage 20-40 mg~Size of nodule/cord: 2-6 cm2, dosage 40-80 mg~Size of nodule/cord: 6-10 cm2, dosage 80-100 mg~Size of nodule/cord: \>10 cm2, dosage 100-120 mg"

Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Division of Plastic Surgery, Toronto

All Listed Sponsors
collaborator

Canadian Society of Plastic Surgeons

OTHER

lead

Sunnybrook Health Sciences Centre

OTHER

NCT00565019 - Effects of Steroid Injection With Percutaneous Needle Aponeurotomy in Dupuytren's Contracture | Biotech Hunter | Biotech Hunter